Searched for
BIOLOGICS JAYANTH SRIDHAR
Dr Reddy's application for biosimilar candidate accepted for review by USFDARituximab is used to treat certain autoimmune diseases and types of cancer. "This milestone underscores our capability for global clinical ...- Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidateFollowing completion of the full set of clinical studies, Dr Reddy's said it will now prepare to file in the US, European Union and other r...
- Dr Reddy's Lab completes Phase 1 study of proposed arthritis drugDr Reddy's Laboratories Ltd on Monday said it has successfully completed the Phase 1 study of its proposed biosimilar of Tocilizumab to be ...
- Load More